Biotechnology company Complement Therapeutics has appointed a new member to its board to help support the company with its development goals.   Complement Therapeutics appointed Steve Axon as in independent director to its Board of Directors who will help the company with its goals of addressing unmet needs in complement mediated diseases such as geographic atrophy due […]